Disclosed in this patent are methods of generating antigen-loaded dendritic cells useful for cancer immunotherapy, through the differentiation of hematopoietic stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.